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Ras makes a pit stop
R
as proteins are restless, con-
tinually fl  itting from the cell 
membrane to the Golgi ap-
paratus and back again. Misaki et 
al. reveal that the proteins enter 
recycling endosomes during the 
journey to the plasma membrane.
One mystery is why Ras pro-
teins—which spur cell growth, dif-
ferentiation, and survival—move 
so often. The cluttered cell interior 
has also made it diffi  cult to discern 
how the proteins travel. Proteins heading for the Golgi might zip 
through the cytosol or hitchhike in endosomes. Some evidence 
suggests that they pass through recycling endosomes, whereas 
other studies indicate they shun the endocytic pathway altogether.
Misaki et al. used COS-1 cells in which recycling 
endosomes are easier to observe because they gather in the so-
called Golgi ring near the organelle, separate from early and late 
endosomes. The researchers found that Ras proteins do spend 
time in recycling endosomes, but only on the outbound leg from 
the Golgi to the cell membrane. Addition of two palmitoyl groups 
directs Ras to recycling endosomes, the team discovered.
The researchers think that an unidentifi  ed vesicle ferries 
the proteins from the Golgi to the recycling endosomes. Whether 
recycling endosomes deliver Ras proteins to the cell membrane 
or hand off their cargo to other carriers is unclear. Receptors such 
as the epidermal growth factor receptor also slip into recycling 
endosomes and might activate Ras proteins there.
Misaki, R., et al. 2010. J. Cell Biol. doi:10.1083/jcb.200911143.
CLIP catches enzymes in the act
P
roprotein convertases (PCs) 
are big shots in the body 
because they snip and turn on 
numerous hormones, receptors, adhe-
sion molecules, and other crucial 
proteins. Mesnard and Constam 
describe a new technique to track 
the activity of some of these ubiqui-
tous but hard-to-study enzymes.
The targets of the nine PCs 
range from insulin to the blood 
pressure regulator renin to several 
proteins implicated in Alzheimer’s 
disease. Cancer cells and pathogens such as HIV often co-opt 
the enzymes for nefarious ends. For example, PCs turn on matrix 
metalloproteinases that clear away extracellular matrix and allow 
cancer cells to spread. But the enzymes’ widespread distribution 
and overlapping functions have made it diffi  cult to tease out what 
jobs individual enzymes perform.
To simplify the task, Mesnard and Constam devised a 
method to determine when and where PCs are working. They 
fused yellow and blue fl  uorescent proteins to create a biosensor 
they call CLIP. When PCs are absent, the two colors remain 
together. But active PCs cut CLIP and separate the colors. 
Researchers can thus track PC activity inside a cell and at its 
surface, or even in whole tissues. Mesnard and Constam used the 
approach to fi  nd out when two PCs, Pace4 and Furin, switch on 
in early mouse embryos. The enzymes were on the job before the 
blastocyst implanted, earlier than expected. The researchers say 
that CLIP could improve drug design, allowing scientists to pin 
down where certain PCs are functioning in diseases and monitor 
the effectiveness of inhibitors dispatched to those sites.
Mesnard, D., and D.B. Constam. 2010. J. Cell Biol. doi:10.1083/
jcb.201005026.
Yellow and blue have sepa-
rated in this mouse blasto-
cyst, indicating that two PCs 
are active.
How a virus enters without breaking
V
iral glycoproteins are 
the fl  exible keys to 
the cell. By changing 
shape, they open the cell so that 
the virus can enter. Libersou et 
al. show how one glycoprotein 
helps the vesicular stomatitis 
virus (VSV) gain access to 
mammalian cells.
Glycoprotein contor-
tions reshape the viral and cellular membranes, allowing them 
to fuse. VSV carries a surface glycoprotein called G. Previ-
ous work indicated that G has at least three confi  gurations—a 
pre-fusion state, an intermediate form that interacts with the 
target cell membrane, and a post-fusion conformation. Using 
electron microscopy and tomography, Libersou et al. tracked 
G to determine how its alterations spur fusion of VSV particles.
Instead of going in tip fi  rst, the virus, which is shaped like a 
bullet, backs in with its fl  at base. Low pH triggers the viruses to fuse 
and trips G molecules into the post-fusion arrangement. However, fu-
sion requires more than gymnastics by G. The researchers found that 
if they reduced the pH just enough so that the glycoproteins distorted 
into the post-fusion shape, the viral particles remained locked out.
G undergoes another transformation—glycoproteins not 
located on the viral base interconnect to form helical arrays. 
The arrays can also reshape membranes, the researchers found. 
Libersou et al. conclude that fusion requires two rearrangements 
of G. First, glycoproteins on the viral base remodel and establish 
a connection with the cell membrane that initiates fusion. Then G 
molecules on the sides of the virus connect into helices that can 
deform the viral membrane to fully achieve fusion.
Libersou, S., et al. 2010. J. Cell Biol. doi:10.1083/jcb.201006116.
Ras proteins (green) huddle 
inside the ring-shaped Golgi 
apparatus (red).
VSV particles in the process of 
fusing with liposomes.